Cellular activities that lead to organogenesis are mediated by epithelial-mesenchymal interactions, which ultimately result from local activation of complex gene networks. Fibroblast growth factor (FGF) signaling is an essential component of the regulatory network present in the embryonic lung, controlling proliferation, differentiation and pattern formation . However, little is known about how FGFs interact with other signaling molecules in these processes. By using cell and organ culture systems, we provide evidence that FGFs, Sonic hedgehog (Shh), bone morphogenetic protein 4 (BMP-4), and TGFb-1 form a regulatory circuit that is likely relevant for lung development in vivo. Our data show that FGF-10 and FGF-7, important for patterning and growth of the lung bud, are differentially regulated by FGF-1, -2 and Shh. In addition, we show that FGFs regulate expression of Shh, BMP-4 and other FGF family members. Our data support a model in which Shh, TGFb-1 and BMP-4 counteract the bud promoting effects of FGF-10, and where FGF levels are maintained throughout lung development by other FGFs and Shh. q
Introduction
Classical and more recent studies have shown that lung branching morphogenesis and differentiation result from interactions between the developing epithelial bud and its surrounding mesenchymal cells. These interactions ultimately re¯ect activation of local gene networks along the proximal-distal axis of the respiratory tract which coordinates the temporal-spatial appearance of buds and clefts, resulting in the bronchial tree (reviewed in Hogan, 1999) . Correct patterning and speci®cation of phenotypes are ensured by a complex feedback regulation of these signals, controlling cell proliferation, differentiation, migration and cell death.
Fibroblast growth factors (FGF) are essential components of the gene network that regulates lung development. FGF-10 plays a fundamental role in branching morphogenesis. At early stages, FGF-10 is expressed at high levels in the distal lung mesenchyme in a pattern that appears to correlate with sites of prospective bud formation ( Bellusci et al., 1997a,b) . We have shown that FGF-10 is a potent chemotactic factor for the distal lung bud, being able to direct bud outgrowths to proper positions in lung organ cultures (Park et al., 1998) . FGF-10 disruption in knock out mice causes perinatal lethality with complete absence of lungs (Min et al., 1998; Sekine et al., 1999) . FGF-7 can be also detected in the early lung and, together with other factors, plays a role in epithelial branching in vitro, acting as a proliferative factor for the lung epithelium (Post et al., 1996; Park et al., 1998) . Both FGF-7 and FGF-10 bind to FGFR2 IIIb, which is expressed at high levels in the embryonic lung epithelium at early stages (Peters et al., 1992; Cardoso et al., 1997) . Targeted expression of a dominant-negative FGFR2 in the lung epithelium or expression of a soluble dominant-negative FGFR2 mutant in transgenic mice result in blockade of lung branching morphogenesis (Peters et al., 1994; Celli et al., 1998) . FGF-1, a ligand that binds all FGFRs with high af®nity, has been also implicated in patterning of the embryonic lung epithelium. In mesenchyme-free lung epithelial cultures, FGF-1 induces budding, in contrast to FGF-7 which promotes cyst-like growth and induces epithelial differentiation (Cardoso et al., 1997) . Fibroblast growth factor signaling via FGFR-3 and -4 is also important for postnatal lung development, regulating alveolization (Weinstein et al., 1998) .
Studies in other developing systems have shown that the multiple roles of FGFs result from interactions with regulatory molecules present in the surrounding environment (reviewed inMartin, 1998) . Several of the above mentioned genes are also expressed in the developing lung. Thus, it is reasonable to think that cellular activities that have been ascribed to FGFs may be either controlled by, or result from, the activation of regulatory pathways involving FGFs and some of these genes. Sonic hedgehog is an important regulatory molecule predominantly found in the distal lung epithelium, that in¯uences epithelial patterning by regulating mesenchymal cell proliferation and expression of a variety of mesenchymal genes. Altered expression of Shh or its targets, Gli genes, in mutant mice dramatically affects lung morphogenesis (Bellusci et al., 1997a,b; Grindley et al., 1997; Litingtung et al., 1998; Motoyama et al., 1998; Pepicelli et al., 1998) . Several members of the TGFb superfamily including BMPs and the TGFb subfamily are also expressed in the lung; studies in organ culture and in transgenic mice have shown that they are negative regulators of airway branching, differentiation and epithelial cell proliferation (Heine et al., 1990; Bellusci et al., 1996; Zhou et al., 1996a,b) .
While all the above signals are likely integrated into a program that speci®es lung patterning, it is still unclear how FGFs and these signaling pathways interact in the embryonic lung. Here we approached this question focusing on FGF-10 and FGF-7 because of their presence throughout lung development and their distinct effects on epithelial patterning and differentiation. Potential gene interactions were investigated using lung organ and cell cultures. Our results suggest the presence of regulatory circuits, where expression of FGFs can be differentially regulated by Shh and by FGF family members, and support a former model (Bellusci et al., 1997a,b) in which budding is controlled by interactions between the growing tip epithelium and the chemotactic center in the mesenchyme. Such mechanism appears to involve FGF-10, BMP-4 and TGFb-1.
Results
FGF-7 and FGF-10 are important mesenchymal components of the gene network that regulates lung development. Consistent with the idea that soluble factors in the epithelium are responsible for induction or maintenance of mesenchymal gene expression, we assessed expression of these FGFs by semi-quantitative PCR in day 16 embryonic lung mesenchymal cultures. By 48 h, we observed that in the absence of the epithelium, these cells have a marked increase in the mRNA levels of FGF-10 and a decrease in FGF-7 relative to the levels at 24 h (Fig. 2 ). As one of the possible explanations for this, we speculated that epithelial cells in the intact lung secrete factors which are inhibitory for FGF-10 and stimulatory for FGF-7. We carried out an investigation to better understand how epithelial-mesenchymal interactions occur at the gene expression level, and to identify potential regulators and targets of these FGFs in the lung. Fig. 2 . FGF expression in embryonic lung mesenchymal cells growing in control conditions for 48 h. Semi-quantitative RT/PCR shows that in the absence of the epithelium, mRNA levels of FGF-7 in these cells are reduced, while FGF-10 levels markedly increase from 24 to 48 h in culture (*P , 0:05). Gene expression (optical density, OD, arbitrary units) was quanti®ed by gel image analysis and was normalized by respective values of b-actin. Fig. 1 . Schematic representation of the culture systems used to study FGF interactions in the developing mouse lung in vitro. (A), embryonic lung mesenchymal cell cultures; (B) whole lung cultures. Gene expression was assessed in both systems by semiquantitave RT/PCR and/or in situ hybridization. A detailed description of the assays can be found in Section 5.
Regulation of FGF-7 gene expression
The observation that Shh signals in the lung epithelium decrease throughout development, while FGF-7 levels conversely rise from early to late gestation (Bellusci et al., 1997a,b; Park et al., 1998) led us to hypothesize that these genes could regulate expression of each other. As a representative regulator missing in the mesenchymal cell culture system, we checked the contribution of Shh to the decrease in FGF-7 expression observed at 48 h shown in Fig. 2 . To determine the concentration effective to activate Shh signaling, lung mesenchymal cells were cultured in the presence of recombinant Shh at 1.4, 7, and 14 mg/ml for 48 h and expression of Ptc mRNA was detected by semi-quantitative RT/PCR. Fig. 3A shows that Ptc mRNA is upregulated in a dose-dependent manner, and that within that range, maximal activation is achieved at 14 mg/ml. Based on this observation and on data from other studies (Yang et al., 1997; Amthor et al., 1999) , this concentration was selected to treat cells in subsequent experiments (Fig. 3B,C) . We then compared the effect of Shh treatment on FGF expression in mesenchymal cells at 24 and 48 h. Fig. 3B shows that, while repressing FGF-10 (discussed in a subsequent section), Shh causes a 2±2.5 fold increase in FGF-7 gene expression in these cells. The effect is present at 24 h, but a statistically signi®cant increase in FGF-7 over controls is seen at 48 h treatment (Fig. 3B,C) . Although the experiments shown in Figs. 2 and 3B,C cannot be directly compared, it is likely that at least part of the decrease in FGF-7 expression in cells growing in the absence of the epithelium at 48 h is due to the Shh withdrawal from the system. Trace levels of Shh were found only by radiolabeled PCR, and could be accounted for by the less than 1% of epithelial cells in the system, as assessed by vimentin staining (not shown).
Based on evidence that FGFs regulate expression of other family members during limb development (reviewed in Martin, 1998) , we tested the hypothesis that FGF-1, -2 and -10, all present in the developing lung, may in¯uence FGF-7 expression. Thus, we used recombinant FGF-1 and -2 in lung mesenchymal cultures, and assessed FGF-7 mRNA, as we did with Shh. Effective doses were determined by testing concentrations ranging from 10±500 ng/ ml. Fig. 4 shows that treatment with either FGF-1 or FGF-2 induces a concentration-dependent increase in the levels of FGF-7 mRNA at all doses, without affecting FGF-10. The effect is maximal at 48 h, however a trend toward an upregulation of FGF-7 is already seen within 24 h in both cases. In contrast, FGF-7 expression is not induced by treating whole lung cultures with recombinant FGF-10 (data not shown).
Downstream of FGF-7
FGF-7 is a mesenchymal factor that in¯uences lung bud growth and differentiation by signaling via its high af®nity epithelial receptor FGFR-2 IIIb (Peters et al., 1992; Igarashi et al., 1998) . In order to identify potential targets in the epithelium, lungs on day 11.5 were cultured in the presence of recombinant FGF-7. As we have previously shown, FGF-7-soaked beads induce extensive proliferation and dilation in epithelial tubules around the bead (Park et al., 1998) . We performed in situ hybridization in these cultures and compared gene expression in affected versus control areas. Based on the Shh-FGF-7 interaction described in the previous section, we tested the possibility that an FGF± Shh regulatory loop might exist in the lung. We found that, within 24 h, levels of Shh (Fig. 5A ) are substantially reduced in the epithelium associated with the FGF-7 bead (arrow), as compared to control areas (arrowhead). Shh downregulation is supported by a parallel decrease in Ptc levels (Mariago and Tabin, 1996) . Fig. 5B shows the marked difference in Ptc levels between unaffected mesenchyme (arrowhead) and mesenchyme adjacent to the bead (arrows). The FGF-7 effect on Shh appears to be ligand-dependent, since it is not found in lungs grafted with FGF-10-beads (Fig. 5A ). It is intriguing that these FGFs, despite sharing high degree of homology and binding to the same FGFR2 IIIb, have such different effects in the lung. (Igarashi et al., 1998; Park et al., 1998) . The effect of FGF-7 on both Shh and Ptc expression extends to areas that are sometimes located many cell diameters distal to the bead implantation site, in agreement with previous observation that this growth factor acts as a long-range signal in lung cultures (Park et al., 1998) .
We have also shown that FGF-1 regulates FGF-7 expression in the developing lung in vitro (Fig. 4) . Here we tested if FGF-1, another potential epithelial target, in turn, could be regulated by FGF-7. In situ hybridization in lung cultures grafted with FGF-7 beads for 2 days shows that in control areas FGF-1 transcripts are still weakly detectable (arrowhead in the right panel of Fig. 5C ). The low level signals present in these cultures are in agreement with the pattern seen in airways at around this developmental stage in vivo (Bellusci et al., 1997a,b and Cardoso et al., unpublished data) . In contrast, FGF-1 signals are increased in the epithelium associated with the FGF-7 bead (arrow in Fig. 5C ). This effect was con®rmed by assessment of FGF-1 mRNA in mesenchyme-free lung epithelial cultures treated with FGF-7 (Cardoso et al., 1997) (data not shown).
We also investigated the transcription factor TTF-1 as a potential FGF target in the epithelium, based on its involvement in lung epithelial branching and differentiation (Bohinski et al., 1994; Minoo et al., 1995; Kimura et al., 1996; Aubin et al., 1997) .
TTF-1 is strongly expressed in the distal lung epithelium, although expression in proximal mesenchyme has also been recently reported (Aubin et al., 1997) . Mutant mice lacking TTF-1 do not develop branching of the lower bronchial tree, generating instead cystic dilated lungs (Kimura et al., 1996) . While cystic dilation of airways is a phenotype that also occurs in FGF-7-treated lungs (Shiratori et al., 1996; Park et al., 1998) , we found that TTF-1 expression in lung cultures was not altered by exogenous FGF-7. Fig. 5D shows that labeling intensity in the cell layer around the bead (arrow) is equivalent to that found in typical control airways (arrowhead).
Regulation of FGF-10 gene expression
Despite the relative decline in the proportion of mesenchyme to epithelium from early to late stages of development, the embryonic lung expresses increasing levels of FGF-10 mRNA (Bellusci et al., 1997a,b) . Our observation that isolated lung mesenchymal cells have a sharp upregulation of FGF-10 gene expression from 24 to 48 h in culture (Fig.  2) suggests that inhibitory factors in the epithelial layer might be an important component of the FGF-10 regulatory mechanism in the developing lung. These factors might have a prominent role at early stages, tightly controlling FGF-10 levels during branching. Previous studies in which Shh was upregulated in the lung by RA treatment, or overexpressed in transgenic mice, strongly suggested that FGF-10 levels are controlled by Shh (Bellusci et al., 1997a,b) . We cultured lung mesenchymal cells in the absence or in the presence of recombinant Shh at 14 mg/ ml, a concentration that most effectively upregulated Ptc expression (Fig. 3A) , assessing changes in FGF-10 mRNA expression. While 24 h-levels of FGF-10 in treated and untreated cultures were roughly similar, Shh had an inhibitory effect on FGF-10 expression at 48 h (Fig.  3B,C) , dramatically blocking the rise in expression observed in controls (Figs. 2 and 3C ). The idea that uninhibited lung mesenchyme produces high levels of FGF-10 transcripts is also supported by the widespread expression of this gene in lungs of Shh knockout mice (Pepicelli et al., 1998) . Nevertheless, it is unclear why effective inhibition in our system occurred only at 48 h. Perhaps the process involves changes in proportion of speci®c mesenchymal cell populations. If the mesenchymal system constitutes a mixture of responding-and non-responding cells, prolonged exposures to Shh treatment may be necessary to induce detectable changes in gene expression. Alternatively, the effect of Shh may be indirect, requiring activation of intermediate steps. Further studies will be necessary to clarify this issue.
Still using the mesenchymal cell system, we found that regulation of FGF-10 differs from FGF-7 regarding to its response to other FGFs. Fig. 4 shows that FGF-10 expression in lung mesenchymal cells is unaffected by treatment with recombinant FGF-1 or FGF-2, while both proteins enhance FGF-7 expression.
Furthermore, we investigated the possibility that other mesenchymal factors could be contributing to regulation of FGF-10. TGFb-1 was a good candidate to test, given its inhibitory role in several aspects of lung development (Serra et al., 1995; Zhao et al., 1996a,b) . Lung mesenchymal cells were cultured in recombinant TGFb-1 (1 and 10 ng/ml) or TGFb-2 (1 and 5 ng/ml). The latter, although being expressed in the epithelium, was used as another control for the TGFb-1 effects. Semiquantitative PCR shows that both proteins inhibit FGF-10 expression in a dose-dependent manner by 6 h treatment (Fig. 6A) , in agreement with similar ®ndings in a ®broblast cell line (Beer et al., 1997) . TGFb-2 appears to be a more powerful inhibitor than b-1, since the maximal effect on FGF-10 expression is obtained with about half the concentration of b-1. Interestingly, by 24 h incubation with these growth factors, FGF-10 regulation becomes refractory to both TGFbs, and levels of expression in treated and control cultures are similar (data not shown). Although growth factor degradation could be playing a role in this response (maximal activity occurs within initial 20 h), it is conceivable that inhibition by TGFb-1 is more dif®cult to achieve after 24 h because mesenchymal cells are growing without other negative regulators of FGF-10 from the epithelium. The inhibitory effect on FGF-10 was con®rmed by grafting a TGFb-1 bead in whole lung explants cultured for 6 h. Fig. 6B shows a typical expression of FGF-10 in the distal mesenchyme in control areas (arrowhead), that is absent in the lung that contains the bead (arrow). The interaction reported here in cultures may re¯ect the restricted expression pattern of these growth factors in vivo. In day 11.5 embryomic mouse lungs, TGFb-1 mRNA is found in the subepithelial mesenchyme at sites where FGF-10 expression is excluded (Fig. 6C) .
Downstream of FGF-10
To identify potential FGF-10 targets, we grafted beads onto day 11.5 lungs and analyzed gene expression in these cultures, as previously described. FGF-10 exerts a chemo- tactic effect in distal epithelial buds, deviating bud growth and generating a double-layered epithelial structure around the bead (Park et al., 1998) . In situ hybridization analysis of Shh (Fig. 5A) , TTF-1 (Fig. 5D) , Ptc (not shown) and FGF-1(not shown) failed to show changes in gene expression in areas associated with the FGF-10 bead, at 24-or 48 h-treatment.
We then assessed BMP-4 expression for its potential role in counteracting the FGF-10 effects during budding (reviewed in Hogan, 1999) . BMP-4, a TGFb-related homolog of the Drosophila dpp , is found in the lung at restricted sites in the distal epithelium (arrowhead in Fig. 6C,D) and at a lesser extent in the mesenchyme (Bellusci et al., 1996) . In situ hybridization analysis in FGF-10-treated lung cultures showed that BMP-4 expression was markedly upregulated in the epithelium in contact with the FGF-10 bead already within the initial 24 h in culture (arrow in Fig. 6D ).
Discussion

FGF-10 interactions and implications in lung budding
Previous studies suggest that the establishment of FGF-10 gradients in the lung mesenchyme is important for patterning of the distal epithelium ( Bellusci et al., 1997a,b; Park et al., 1998) . Such gradients might be tightly controlled by a local network, in which potential negative regulators of FGF-10 such as Shh, play a role (Bellusci et al., 1997a,b) . A model has been previously proposed in which epithelial budding is triggered by the appearance of a chemoattractant source in the mesenchyme; budding is restricted by a negative feedback between the growing epithelial bud and the chemoattractant source (Bellusci et al., 1997a,b; Hogan, 1999) .
We have revisited this model by assessing FGF interactions with other pattern regulators in culture systems to have a better understanding of how chemoattraction and bud elongation could be controlled during bud formation. Our bead assay simulated a situation where chemoattraction (FGF-10) or growth (FGF-7) were exaggerated by high levels of a regulator ®xed in time and space in the developing lung. The mesenchymal cultures allowed us to test the effect of individual regulators in the absence of confounding epithelial factors.
Our data con®rm the involvement of Shh in the control of FGF-10 levels and include a role for BMP-4 and TGFb-1 as candidate genes to limit lung bud outgrowth. We found that FGF-10 upregulates BMP-4 expression, but is negatively regulated by TGFb-1. Further studies will be necessary to determine whether the FGF effect on BMP-4 is direct, or requires activation of other molecules. Shh could be a mediator of these interactions, based on the observation that high levels of BMP-4 are found in the lung epithelium of Shh-knock out animals (Pepicelli et al., 1998) . However, the fact that FGF-10 beads did not affect Shh expression in our cultures argues against this hypothesis. Furthermore, the levels of BMP-4 in the distal lung of transgenic mice overexpressing Shh are similar to those in wild types (Bellusci et al., 1996) . By integrating our data into the original model, we propose a current model summarized in Fig. 7 , and subsequently described. In the early lung, the appearance of an FGF-10 source in the presence of proliferation factors in the mesenchyme (Warburton et al., 1992; Ohmichi et al., 1998; Park et al., 1998) triggers epithelial branching. A bud is induced and growth is directed toward the FGF-10 source. A feed back regulation is established between the growing tip bud and the FGF10-expressing cells to control budding. Fig. 7 . FGF-10 interactions and the control of epithelial bud formation in the developing lung. Our current data have been incorporated into a former model (Bellusci et al., 1997a,b) and is summarized in this diagram. (A) In the early lung, local expression of FGF-10 in the mesenchyme induces directional growth (B). As the bud approaches these cells, a feedback is established between the tip epithelial bud and FGF-10-expressing cells. Proliferation is inhibited by FGF-10 -mediated upregulation of BMP-4 at the tips, and also by TGFb-1 expressed throughout the subepithelial region. Chemoattraction is inhibited when FGF-10 expression is downregulated by high levels of Shh/Ptc at the leading edge of the growing bud and by subepithelial TGFb-1. (C) Simultaneous local repression of FGF-10 and inhibition of epithelial cell proliferation limits bud outgrowth and expansion, resulting in cleft formation. As the inital chemotactic center is extinguished, other FGF-10 foci appear at different sites to induce a new generation of buds. At the cleft, low levels of FGF-10 are maintained by subepithelial TGFb-1, which also stabilizes the cleft by synthesizing matrix components deposited in the epithelial-mesenchymal interface.
As the bud approaches the FGF-10 area, BMP-4 is upregulated by FGF-10, resulting in increased distal activation of BMP signaling to limit tip bud proliferation. Epithelial proliferation is also inhibited by TGFb-1, expressed throughout the subepithelial regions, which binds and activates epithelial receptors. TGFb-1 expression may be induced and maintained by epithelial factors, and its presence in the subepithelial mesenchyme may serve to attenuate mitogenicity promoted by growth factors such as EGF (Lee et al., 1997) . At the leading edge, high levels of Shh inhibit FGF-10 in the chemotactic center. In addition, FGF-10-expressing cells, then under the in¯uence of subepithelial TGFb-1, have their FGF-10 levels further inhibited. TGFb-1 may have a dual effect as a negative regulator of budding, acting on chemoattraction and on epithelial growth. Other mechanisms to limit budding not included in this model are represented by the FGF antagonist members of the sprouty (spry) family of genes (Hacohen et al., 1998; DeMaximy et al., 1999; Tefft et al., 1999) . As the initial chemotactic center is extinguished, other FGF-10 foci appear at different sites to induce a new generation of buds. The former bud becomes a cleft; Shh is no longer expressed at high levels at this site. Low levels of FGF-10 are maintained by subepithelial TGFb-1, preventing local budding. TGFb's role on stabilizing the cleft is also reinforced by its ability to synthesize matrix components (Heine et al., 1990) , that are deposited in the epithelial-mesenchymal interface.
FGF-7 forms a regulatory loop with Shh and other FGFs in the developing lung
During early limb development, positive feedback loops involving several FGF members and Shh function to induce the zone of polarizing activity and maintain limb development (reviewed in Martin, 1998) . In the present work, we provide evidence that feedback mechanisms involving these genes are likely to be present in the developing lung. Former studies suggest that the high levels of Shh in the early lung serve to maintain an appropriate amount of mesenchyme, thus supplying factors used for growth and patterning of nascent epithelial bud (Litingtung et al., 1998; Pepicelli et al., 1998) . Our data show a modest but signi®cant stimulatory effect of Shh on FGF-7 expression in vitro. We propose that early signals, such as Shh, play a role in the establishment of FGF-7 expression in the developing lung. At day 11.5, FGF-7 and FGF-2 mRNAs are found only by PCR, but levels become detectable by in situ hybridization 1±2 days later (Mason et al., 1994; Post et al., 1996; Bellusci et al. 1997a,b; Cardoso et al., 1997; Park et al., 1998; and FGF signaling systems in the developing lung in vivo at early, mid-, and late gestation, based on data from our in vitro assays. Thickness of the lines in boxes containing the factor was used to re¯ect the levels of gene expression at a certain time point. Large squares and ellipses represent epithelium and mesenchyme, respectively. At early stages, high levels of Shh and Ptc (thick boxes) contribute to establish FGF-7 expression which, together with FGF-2, is found at low levels (dotted boxes) in the mesenchyme. Although still not signi®cant, a negative loop regulation of Shh and Ptc starts to take place induced by FGF-7. By midgestation, FGF-2 is found at suf®cient levels to enhance FGF-7 expression. Increasing levels of FGF-7 then start inducing FGF-1 expression in the epithelium (dotted box), which in turn also enhances and maintains FGF-7 expression (positive loop). At late stages high levels of FGF-1, -2 and -7 (thick boxes) contrast with the low levels of Shh and Ptc (dotted boxes). Negative regulation of Shh by FGF-7 is signi®cant at this point. Expression of FGF-7 is no longer maintained by Shh, depending on FGF-1 (positive loop regulation) and FGF-2.
et al., unpublished data). This increase in FGF-7 could be ascribed to stimulation not only by Shh, but also by FGF-2, which we have shown to upregulate FGF-7 expression. The increase in FGF-7 levels at early stages is expected to be slow and progressive. As a potent proliferative stimulus, levels of FGF-7 might be tightly controlled to allow correct epithelial patterning. High levels of FGF-7 in lungs on day 11.5 impair normal branching, by interfering with the chemotactic gradients established by FGF-10, and inducing the epithelium to form large cyst-like structures (Shiratori et al., 1996; Cardoso et al., 1997; Park et al., 1998) .
Coincident with the increase in FGF-2 and -7 levels, days 13 and 14 are also stages when FGF-1 transcripts are ®rst detected by PCR (Park et al., 1998) ; from then on, levels of these FGFs increase in parallel. We found that recombinant FGF-7 upregulates FGF-1 expression in the lung epithelium (Fig. 5C) . Thus it is possible that, in the developing lung, induction of FGF-1 is triggered after a certain threshold level of FGF-7 expression is achieved. We found that in turn, recombinant FGF-1 stimulates FGF-7 mRNA expression in lung mesenchymal cells. Our data suggest the existence of a positive loop regulation involving FGF-7, FGF-1 and FGF-2. This mechanism may be particularly relevant for the maintenance of FGF-7 expression in the lung at later stages since Shh, likely an early inducer of FGF-7, is present at progressively lower levels by mid-to late gestation (Fig. 8) . We have not determined what in¯uences the appearance of FGF-2 initially. Our data show that Shh signaling is unlikely involved, since recombinant Shh did not affect FGF-2 expression in our system (Fig. 3C ). This growth factor seems to act primarily as a proliferation factor for the lung epithelium (Han et al., 1992; Nogawa and Ito, 1995) . Our work reveals an additional function for FGF-2, that is maintenance of FGF expression during development.
Several studies have shown that, toward late gestation, increasing levels of FGF-7 parallels with a decline in Shh and Ptc in the lung (Mason et al., 1994; Cardoso et al., 1996; Bellusci et al., 1997a,b; Park et al., 1998) . Interestingly, we found that Shh and Ptc signals are signi®cantly reduced around sites of FGF-7-bead implantation in lung cultures. This leads us to propose that a negative regulatory loop involving FGF-7 and Shh (Fig. 8B) is established throughout lung development, resulting in a progressive decline in Shh expression. Perhaps this regulatory loop is functionally relevant at late developmental stages, determining the predominance of epithelial over mesenchymal cells. FGF±Shh interactions here contrast with those seen in the developing limb, where FGFs actually help maintain Shh expression in the zone of polarizing activity (reviewed in Martin, 1998) .
The changes in gene expression observed in FGF±Shh or FGF±FGF interactions do not seem to involve changes in the levels of FGFRs expressed in the early lung epithelium (Peters et al., 1992; Cardoso et al., 1997) . We have not found differences in expression of FGFR-2 or -4 mRNA in areas associated with FGF beads in our cultured lungs (data not shown).
Conclusion
The data in the present work suggest that interactions of FGF-7 and FGF-10 with Shh, TGFb, BMP and other FGF family members may be important to control bud formation and maintain adequate levels of growth factors in the developing lung. It is intriguing that FGF-7 and -10, while sharing considerable homology and binding to the same receptor, have such different effects and gene interactions in the lung (Igarashi et al., 1998) . Many studies in vitro (Ulich et al., 1994; Shiratori et al. 1996; Cardoso et al., 1997; Shannon et al., 1999) and a model of gain of function in vivo (Simonet et al., 1995) have shown that FGF-7 is an important mediator of lung epithelial cell proliferation and differentiation; however its absence in knock-out mice has apparently no impact in lung development (Guo et al., 1996) . The explanation for this observation is still unclear and underlines the complexity of the FGF system in vivo. The growing list of FGFs found in the developing lung argues for a more intricate regulatory network, with interactions that are yet to be explored. In this regard, FGF-18 has been recently described during organogenesis in very restricted sites which includes the lung (Ohbaiyashi et al., 1998) . Whether the FGF diversity re¯ects a high degree of redundancy or additional speci®c functions, is still unknown. Furthermore, some of these redundant functions may be manifest by the synergistic effect that growth factors from different families have with each other during morphogenesis. For instance, hepatocyte growth factor (HGF) synergistically stimulates epithelial budding induced by FGFs in lung organ cultures (Ohmichi et al., 1998) , an effect that is similar to that found when FGF-7 is added to FGF-10 treated epithelial cultures (Park et al., 1998) .
Experimental procedures
Primary lung mesenchymal cell cultures
Mesenchymal cell cultures were obtained by differential adhesion (Scott et al., 1983; Caniggia et al., 1991) . Brie¯y, embryonic mouse lungs isolated from timed-pregnant CD-1 mice at gestation day 16.5 were dissociated after treatment with 0.1% collagenase/0.01% DNAase (378C, 30 min). The resulting suspension of mesenchymal and epithelial cells was ®ltered with 100 mm mesh nylon clot, spun at 1000 rev./min for 7 min at room temperature, and the cell pellet was resuspended in 5 ml of DMEM 2% heat-inactivated fetal calf serum. Cell number was estimated in a hemocytometer and further diluted in the same medium to achieve a concentration of approximately 3 £ 10 6 cells/ml. This suspension (1.5 ml) was plated in 30 mm dishes and incubated at 378C, in an air-5%CO 2 incubator for 1 h for differential adhesion. The supernatant containing epithelial cells was removed, while mesenchymal cells, which attached to the dish, were washed twice with PBS and fresh medium was added. Mesenchymal cells were cultured up to 48 h in the presence of either FGF-1 (UBI, human recombinant, 5± 500 ng/ml), FGF-2 (PROMEGA, human recombinant, 5± 500 ng/ml), TGFb-1 and 2 (R&D, human recombinant, 0.1±10 ng/ml), or Shh (mouse recombinant, 1.4, 7.0 and 14 mg/ml, a gift from Dr. Andrew P. McMahon, Harvard Biolabs). Concentrations of recombinant proteins were chosen based on effects on morphology or gene expression previously reported in other systems (Nogawa and Itoh, 1995; Zhao et al., 1996; Yang et al., 1997; Amthor et al., 1999) . Cell cultures were harvested at the appropriate time and total RNA was extracted using Trizol Reagent w (GIBCO-BRL). Fig. 1A shows a schematic view of the procedure. Purity of mesenchymal cell preparations was assessed by immunocytochemical detection of vimentin (SIGMA) staining of cell monolayers in plates ®xed in 4% paraformaldehyde. Contamination with vimentin-negative expressing cells consistently represented less than 1% of the monolayer.
Whole lung organ cultures
Lung explants on day 11.5 gestation were placed on Millipore ®lters (Millipore, Bedford, MA) on the top of stainless-steel grids and cultured in BGJb medium (GIBCO-BRL) containing 0.2 mg ascorbic acid, 50 units/ mg penicillin/streptomycin and 0.1% heat-inactivated fetal calf serum for 2±3 days . Localized effects of FGFs in these cultures were tested by implanting heparin beads (SIGMA) impregnated with human recombinant FGF-10 (100 mg/ml, human recombinant, R&D (50 mg/ml, PROMEGA) in the distal lung, as shown in Fig.  1B and described in our previous publication (Park et al., 1998) . We also tested the effect of TGFb-1 in lung cultures, by grafting Af®-gel blue beads (Bio-Rad) soaked in recombinant protein (7. 5 mg/ml, R&D, human recombinant) as described inGanan et al. (1996) .
Semi-quantitative RT/PCR
Reverse transcription reaction was carried in 500 ng of total RNA; equal amounts of template were loaded for PCR. Ampli®cation was performed with a 32 P dCTP (3000 Ci/ mmol, 40 mCi/ml reaction) for 25±30 cycles in conditions that consisted of 958C for 1 min, 558C for 1 min, and 728C for 1.5 min. Primer sequences (from 5 H to 3 H ), size of ampli®ed products and number of cycles are listed in the references or speci®ed as follows: FGF-2 (435 bp, Ozawa et al., 1996) , FGF-7 (600 bp, Mason et al., 1994) , FGF-10 (AAG CTC TTG GTC AGG ACA TGG TGT and TCC ATT CAA TGC CAC ATA CAT TTG, 458 bp, 25 cycles), b-actin (552 bp, Cardoso et al., 1996) , Ptc (GGA TTA AAG GCA GCT AAT CTC and GGT TGA ATT TTT GTT AGG GGC, 600 bp, 25 cycles). Amplicons were electrophoresed in polyacrylamide gels and processed for autoradiography. Changes in gene expression were evaluated by image analysis of gels (Instant Imager ± Eletronic Autoradiography, Packard Instr.
Co., IL) and in case of Fig. 3A , by densitometry of autoradiographs (Image Quant). Values obtained for the ampli®cation of the gene of interest were normalized by their corresponding actin values, and results were expressed as percentage of control. Linearity and reproducibility were tested as described in Cardoso et al. (1996) . Experimental conditions were tested 3±5 times. Statistical analysis was performed using a Student's t-test; differences were considered signi®cant if P , 0:05.
In situ hybridization
Lung cultures in which FGF-10 or FGF-7 beads had been implanted were ®xed in 4% paraformaldehyde in PBS overnight at 48C. For isotopic in situ hybridization, 5 mm-paraf®n sections were processed using 35 S-labeled riboprobes. Pre-hybridization, hybridization and autoradiography were performed as described previously (Cardoso et al., ,1997 . We assessed expression of Shh, Ptc, BMP-4 (gifts from Dr. Andrew P. McMahon, Harvard Biolabs), FGF-1 (gift from Dr. Ivor Mason, UMDS), and TTF-1 (gift from Dr. Parviz Minoo,USC). Whole mount in situ hybridization of the above genes was additionally performed in these cultures and on day 11.5 mouse lungs, as described in Wilkinson (1992) . Conclusions were based in the analysis of at least three to ®ve specimens or slides for each experimental condition.
